Out of stealth with £2.2m to design cancer combination therapies
A £1.5m pre-seed co-led by Kadmos Capital and Exceptional Ventures, with Gloucester Ventures and angel investor John White, alongside £700k of non-dilutive funding from Innovate UK. The round takes our first designed combinations from the model into the lab.
Read the release (PDF)